drugset / Trial / NCT03488173
Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer
Phase 1
Completed
42 enrolled
First Affiliated Hospital of Zhejiang University
Beijing Xuze Medical Technology Co., LTD. · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study was to compare pharmacokinetic of Lansoprazole Capsules 30 mg with Lansoprazole Capsules of Takeda 30 mg in healthy adult human subjects.
Timeline
- Start
- 2018-04-23
- Primary completion
- 2018-07-19
- Completion
- 2019-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lansoprazole | Other / unclassified | 30 mg | — |
Indications
No indication recorded.